Cutler Group’s Amicus Therapeutics FOLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-10,600
Closed -$5K 5185
2022
Q1
$5K Buy
+10,600
New +$99.4K ﹤0.01% 4116
2021
Q3
Sell
-9,000
Closed -$1K 5900
2021
Q2
$1K Sell
9,000
-17,500
-66% -$171K ﹤0.01% 5284
2021
Q1
$4K Buy
26,500
+9,000
+51% +$139K ﹤0.01% 4504
2020
Q4
$67K Buy
+17,500
New +$358K ﹤0.01% 1799
2020
Q3
Sell
-28,500
Closed -$89K 4850
2020
Q2
$89K Buy
+28,500
New +$347K 0.01% 1370
2018
Q3
Sell
-11,600
Closed -$6K 4296
2018
Q2
$6K Sell
11,600
-501,800
-98% -$7.59M ﹤0.01% 2985
2018
Q1
$215K Buy
513,400
+424,900
+480% +$6.47M 0.02% 789
2017
Q4
$124K Buy
88,500
+49,500
+127% +$680K 0.01% 1248
2017
Q3
$198K Sell
39,000
-6,100
-14% -$80.7K 0.01% 1185
2017
Q2
$82K Sell
45,100
-137,000
-75% -$1.1M ﹤0.01% 2034
2017
Q1
$76K Buy
182,100
+146,700
+414% +$928K ﹤0.01% 2002
2016
Q4
$3K Buy
35,400
+25,500
+258% +$176K ﹤0.01% 5297
2016
Q3
$9K Buy
9,900
+5,900
+148% +$39.9K ﹤0.01% 4305
2016
Q2
$1K Sell
4,000
-54,200
-93% -$379K ﹤0.01% 6057
2016
Q1
$32K Buy
58,200
+42,600
+273% +$302K ﹤0.01% 2773
2015
Q4
$10K Buy
+15,600
New +$141K ﹤0.01% 4126

Other funds holding FOLD

Cutler Group's FOLD Position: Q1 2023 in Review

Cutler Group sold out of Amicus Therapeutics (FOLD) in Q1 2023, closing a stake of 200 shares — an estimated $2K sold.

Cutler Group first reported a position in FOLD in Q4 2015 and held it in 12 quarters. The position peaked at $554K in Q3 2017. 226 funds tracked by Wall St. Rank hold FOLD as of Q1 2023.

  • Cutler Group reported no remaining Amicus Therapeutics position as of Q1 2023 after selling out during the quarter.
  • Cutler Group sold 200 Amicus Therapeutics shares in Q1 2023, an estimated $2K.
  • Cutler Group first reported a position in Amicus Therapeutics in Q4 2015 and held it in 12 quarters.
  • Cutler Group's Amicus Therapeutics position peaked at $554K in Q3 2017.
  • 226 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2023.

Based on Cutler Group's 13F filing for Q1 2023, filed 1 May 2023.